
Mayutel Trio 40mg/5mg/12.5mg Tablet
Marketer
Mayu Health Care
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Mayutel Trio 40mg/5mg/12.5mg Tablet
Trelentrio 40mg/5mg/12.5mg tablets combine multiple agents to manage hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, thereby mitigating the risk of future stroke and heart attack. Trelentrio 40mg/5mg/12.5mg tablets can be taken with or without food; dosage is personalized based on individual response and condition. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial. The formulation includes a diuretic, increasing urination; therefore, avoid ingestion within four hours of bedtime. Regular use maximizes therapeutic benefits, even during asymptomatic periods. Discontinuing treatment elevates stroke and heart attack risk. Commonly reported side effects include headache, dizziness, lethargy, altered taste perception, fatigue, influenza-like symptoms, diarrhea, and sinusitis. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counter potential muscle weakness, dry mouth, and excessive thirst. Prior to commencing treatment, disclose any pre-existing kidney or liver conditions. Pregnant or lactating individuals should seek medical counsel before use. Comprehensive disclosure of all concurrent medications, particularly those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to ensure optimal treatment efficacy.
Uses of Mayutel Trio 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Mayutel Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mayutel Trio 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Mayutel Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Mayutel Trio 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mayutel Trio 40mg/5mg/12.5mg Tablets can be consumed with or without food; however, consistent timing is recommended.
How Mayutel Trio 40mg/5mg/12.5mg Tablet works:
Each Mayutel Trio 40mg/5mg/12.5mg tablet contains telmisartan, amlodipine, and hydrochlorothiazide, three medications working synergistically to manage blood pressure. Telmisartan (an angiotensin receptor blocker or ARB) and amlodipine (a calcium channel blocker or CCB) both promote vasodilation, reducing vascular resistance and blood pressure. Hydrochlorothiazide, a diuretic, facilitates fluid and electrolyte excretion via the kidneys, contributing to lowered blood pressure through diuresis and subsequent vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Mayutel Trio 40mg/5mg/12.5mg tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Employing Mayutel Trio 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in critical circumstances where a physician deems the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Use of Mayutel Trio 40mg/5mg/12.5mg tablets is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by side effects of Mayutel Trio 40mg/5mg/12.5mg Tablets, including dizziness, headache, nausea, or fatigue, which can reduce concentration.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Mayutel Trio 40mg/5mg/12.5mg tablets, as dose modification may be necessary. A physician's consultation is advised. Mayutel Trio 40mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Mayutel Trio 40mg/5mg/12.5mg tablets. Dosage modification of Mayutel Trio 40mg/5mg/12.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Mayutel Trio 40mg/5mg/12.5mg Tablet :
Should you forget to take your Mayutel Trio 40mg/5mg/12.5mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mayutel Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
